Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Perfect Dark reboot cancelled, Initiative Shutdown

Eurogamer on MSN · 2d
Perfect Dark reboot and new Zenimax MMORPG reportedly cancelled as part of latest Microsoft cuts
The reboot of Perfect Dark developed by The Initiative has been cancelled as part of the latest round of cuts at Microsoft.
Windows Central on MSN · 2d
Xbox is cancelling Rare's 'Everwild' and ZeniMax's new MMORPG IP as part of broader cuts — with 'Perfect Dark' possibly impacted as well
As part of broader cuts to the Xbox division, Rare's Everwild and ZeniMax Online Studios' new MMORPG have been canceled.
GameSpot · 2d
Xbox's "AAAA" Perfect Dark Reboot Canceled, Developer Shutting Down
Xbox's Perfect Dark reboot, first announced in 2022, has been canceled. Its developer, The Initiative, is also shutting down, Microsoft has confirmed.
VGChartz
2d
Report: Perfect Dark Gameplay Demo was 'Smoke and Mirrors' - News
Microsoft today announced it is laying off upwards of 9,100 employees, including at the Xbox division. Perfect Dark, Everwild ...
TweakTown
1d
ZeniMax's cancelled Blackbird MMO was highly praised during playtesting, executives loved it
Reports indicate that ZeniMax Online's cancelled MMORPG project 'Blackbird' was a well-liked darling among playtesters and ...
1don MSN
Hideo Kojima's "OD" is still in development with Xbox, at least for today
The Initiative was shut down, leading to the cancellation of Perfect Dark. Everwild at Rare was cancelled, with many senior ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy